Data / Form D filings / Active Genomes Expressed Diagnostics Corp
Active Genomes Expressed Diagnostics Corp: Form D filing
Active Genomes Expressed Diagnostics Corp, a technology company in Washington, DC, filed a Form D with the SEC in 2023. The latest, on February 15, 2023, reports $250,000 sold of a $1.8 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 625 H ST NE, #821, Washington, DC, 20002
- Phone
- (617) 777-7971
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- District Of Columbia
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1964994
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | New notice | $1,750,000 | $250,000 | $1,500,000 | 2 | Dec 29, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachel Zayas | Executive Officer, Director |
Other technology companies in District of Columbia that filed recently
- Pillar Financing, Inc. $250,000 · Oct 28, 2026
- mogul Technologies Inc. $15.5 million · Oct 22, 2026
- Prefect Technologies, Inc. $65.3 million · Aug 25, 2026
- Emerald AI, Inc. $90.2 million · Aug 3, 2026
Every Form D from the week of Feb 13, 2023 · All recent filings in District of Columbia · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Active Genomes Expressed Diagnostics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.